Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:11 AM
Study NCT ID:
NCT04408820
Status:
COMPLETED
Last Update Posted:
2025-07-25
First Post:
2020-05-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-23
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-26
First Submit QC Date:
None
Study First Post Date:
2020-05-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-24
Last Update Post Date:
2025-07-25
Last Update Post Date Type:
ACTUAL